Zevra Therapeutics, Inc. (ZVRA)
NASDAQ: ZVRA · Real-Time Price · USD
13.52
+0.29 (2.19%)
At close: Jun 26, 2026, 4:00 PM EDT
13.73
+0.21 (1.56%)
After-hours: Jun 26, 2026, 7:59 PM EDT
Zevra Therapeutics Employees
Zevra Therapeutics had 61 employees as of December 31, 2025. The number of employees increased by 2 or 3.39% compared to the previous year.
Employees
61
Change (1Y)
2
Growth (1Y)
3.39%
Revenue / Employee
$2,004,738
Profits / Employee
$1,918,049
Market Cap
799.24M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| Phathom Pharmaceuticals | 371 |
| Geron | 258 |
| ARS Pharmaceuticals | 159 |
| Allogene Therapeutics | 152 |
| Aura Biosciences | 113 |
| Odyssey Therapeutics | 100 |
| Inventiva | 77 |
| CytomX Therapeutics | 69 |
ZVRA News
- 5 days ago - Zevra publishes Miplyffa data in Molecular Genetics, Metabolism Reports - TheFly
- 5 days ago - Zevra Therapeutics Announces Publication of Positive MIPLYFFA® Data from Pediatric Substudy in Infants with Niemann-Pick Disease Type C (NPC) - GlobeNewsWire
- 17 days ago - Zevra Therapeutics chief medical officer to step down - TheFly
- 17 days ago - Zevra's Chief Medical Officer to Step Down for Personal Reasons as Part of Planned Transition - GlobeNewsWire
- 17 days ago - Zevra Therapeutics price target raised to $35 from $25 at Maxim - TheFly
- 18 days ago - Zevra Therapeutics price target raised to $29 from $25 at Guggenheim - TheFly
- 19 days ago - Zevra Therapeutics price target raised to $27 from $23 at BTIG - TheFly
- 19 days ago - Zevra Therapeutics price target raised to $29 from $24 at Canaccord - TheFly